Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter

Area of Science:

• Neuropharmacology
• Molecular Neuroscience
• Dopamine Transporter Research

Background:

• Dopamine transporters (DAT) are crucial for regulating dopaminergic neurotransmission.
• Phencyclidine derivatives are used to study DAT and related neuroreceptors.
• Selective affinity labels are needed to investigate the molecular properties of DAT.

Purpose of the Study:

• To investigate the interaction of Fourphit, a novel phencyclidine derivative, with the dopamine transporter.
• To determine if Fourphit can serve as a selective affinity label for the methylphenidate binding site on DAT.
• To compare the binding characteristics of Fourphit with its isomer, Metaphit.

Main Methods:

• Radioligand binding assays using [3H]methylphenidate to measure inhibition by Fourphit.
• Determination of binding kinetics (Bmax and KD) and dissociation rates.
• Comparative binding studies with Fourphit and Metaphit at dopamine transporter and NMDA receptor sites.

Main Results:

• Fourphit irreversibly inhibited [3H]methylphenidate binding to DAT with an IC50 of 7.1 microM.
• Inhibition by Fourphit decreased Bmax but not KD, suggesting direct interaction with the binding site.
• Fourphit selectively targeted the DAT binding site, unlike Metaphit, which also affected NMDA receptors.

Conclusions:

• Fourphit acts as a potent and irreversible inhibitor of methylphenidate binding to the dopamine transporter.
• The data suggest Fourphit is a selective affinity label for the DAT site recognized by psychomotor stimulants.
• Fourphit's ability to discriminate between DAT and NMDA receptor binding sites offers a valuable tool for neuropharmacological research.